Coffee consumption has been reported to be inversely associated with hepatocellular carcinoma (HCC), the most common type of liver cancer.
READ FULL ARTICLE
From cebp.aacrjournals.org
Coffee Consumption Associated with Lower Risk of Hepatocellular Carcinoma
the Cancer Therapy Advisor take:
A significant relationship has been found between coffee consumption and a reduced risk of developing hepatocellular carcinoma (HCC), but not with intrahepatic cholangiocarcinoma (ICC), according to an article published online in the journal Cancer Epidemiology, Biomarkers & Prevention.
Participants in this study included 1,212,893 participants (HCC: n = 860, ICC: n = 260) from the Liver Cancer Pooling Project.
Results showed that increased coffee consumption was associated with a reduced risk of HCC (HR > 3 cups/day vs. non-drinker, 0.73; 95% CI: 0.53, 0.99; Ptrend cups/day < 0.0001). Women who consumed more than three cups of coffee per day had a significantly more reduced risk of HCC (54%) compared to men (HR, 0.46; 95% CI: 0.26, 0.81 compared to HR, 0.93; 95% CI: 0.63, 1.37, respectively; Pinteraction = 0.07).
Caffeinated coffee (HR > 3 cups/day vs. non-drinker, 0.71; 95% CI: 0.50, 1.01) displayed a stronger association with decreased HCC risk than decaffeinated coffee (HR, 0.92; 95% CI: 0.55, 1.54).
The study suggests further evaluations be conducted on specific coffee compounds and mechanisms to better understand their association with reduced HCC risk.
